Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01381029 · ClinicalTrials.gov registry record
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 74
- Enrollment target
NCT01381029 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 74 participants.
The verdict
NCT01381029 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Investigators in the Division of Infectious Diseases are carrying out a study to determine if human immunodeficiency virus (HIV)-seropositive patients receiving the Seasonal Influenza vaccination develop an adequate antibody response. The study group will consist of individuals seen in the Infectious Diseases Clinic who are HIV-seropositive and receive the Seasonal Influenza vaccine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01381029
The ClinicalTrials.gov registry entry for NCT01381029 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01381029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01381029 about?
NCT01381029 is a clinical study titled "Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals". Investigators in the Division of Infectious Diseases are carrying out a study to determine if human immunodeficiency virus (HIV)-seropositive patients receiving the Seasonal Influenza vaccination develop an adequate antibody response. The study group will consist of individuals seen in the Infectiou...
What is the current status of trial NCT01381029?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2009-09. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01381029?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.